scholarly journals Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: a randomized phase‐II study ‐ the PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO ‐0510

2021 ◽  
Author(s):  
Anica Högner ◽  
Salah‐Eddin Al‐Batran ◽  
Jens T. Siveke ◽  
Mario Lorenz ◽  
Prisca Bartels ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Randomized Phase Ii

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer

2010 ◽  
Vol 30 (1) ◽  
pp. 350-356 ◽  
Author(s):  
Sung Yong Oh ◽  
Hyuk-Chan Kwon ◽  
Sang-Ho Jeong ◽  
Young-Tae Joo ◽  
Young-Joon Lee ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Combination Chemotherapy ◽  
Phase Ii Study ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study

2009 ◽  
Vol 20 (6) ◽  
pp. 1062-1067 ◽  
Author(s):  
L. Celio ◽  
C.N. Sternberg ◽  
R. Labianca ◽  
I. La Torre ◽  
V. Amoroso ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

Oncology ◽  
2011 ◽  
Vol 81 (5-6) ◽  
pp. 291-297 ◽  
Author(s):  
Junichi Matsubara ◽  
Yasuhiro Shimada ◽  
Ken Kato ◽  
Yushi Nagai ◽  
Satoru Iwasa ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Advanced Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Weekly Paclitaxel ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document